Mingxi Qiao Selected Research

polyhistidine

1/2020	Stimuli-responsive release and efficient siRNA delivery in non-small cell lung cancer by a poly(l-histidine)-based multifunctional nanoplatform.
8/2019	Multi-Modulation of Doxorubicin Resistance in Breast Cancer Cells by Poly(l-histidine)-Based Multifunctional Micelles.
1/2018	Rational Design of Multifunctional Polymeric Nanoparticles Based on Poly(l-histidine) and d-α-Vitamin E Succinate for Reversing Tumor Multidrug Resistance.
9/2017	Preparation and evaluation of poly(l-histidine) based pH-sensitive micelles for intracellular delivery of doxorubicin against MCF-7/ADR cells.
1/2016	Decoration of pH-sensitive copolymer micelles with tumor-specific peptide for enhanced cellular uptake of doxorubicin.
1/2015	pH-sensitive nanoparticles of poly(L-histidine)-poly(lactide-co-glycolide)-tocopheryl polyethylene glycol succinate for anti-tumor drug delivery.
12/2014	Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin.
5/2014	Self-assembled pH-responsive hyaluronic acid-g-poly((L)-histidine) copolymer micelles for targeted intracellular delivery of doxorubicin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mingxi Qiao Research Topics

Disease

45	Neoplasms (Cancer) 07/2022 - 01/2006
11	Breast Neoplasms (Breast Cancer) 08/2019 - 12/2014
5	Neoplasm Metastasis (Metastasis) 07/2022 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2021 - 01/2020
2	Lung Neoplasms (Lung Cancer) 08/2019 - 01/2018
2	Body Weight (Weight, Body) 01/2018 - 12/2015
1	Weight Loss (Weight Reduction) 12/2019
1	Stroke (Strokes) 11/2018
1	Adenocarcinoma of Lung 01/2018

Drug/Important Bio-Agent (IBA)

12	MicellesIBA 10/2020 - 05/2014
10	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2019 - 12/2014
9	Pharmaceutical PreparationsIBA 08/2021 - 12/2014
8	polyhistidineIBA 01/2020 - 05/2014
7	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2018
5	monomethoxypolyethylene glycol (MPEG)IBA 01/2022 - 04/2016
4	Adenosine Triphosphate (ATP)IBA 05/2022 - 12/2013
4	Hyaluronic Acid (Hyaluronan)IBA 01/2020 - 05/2014
4	Paclitaxel (Taxol)FDA LinkGeneric 03/2019 - 03/2015
4	Peptides (Polypeptides)IBA 01/2016 - 01/2006
3	AcidsIBA 07/2022 - 01/2017
3	PolymersIBA 05/2022 - 01/2015
3	Ethylene Glycol (Monoethylene Glycol)IBA 01/2022 - 09/2017
3	Antineoplastic Agents (Antineoplastics)IBA 08/2021 - 01/2017
3	Liposomes (Liposome)IBA 08/2021 - 01/2006
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2013
3	Folic Acid (Vitamin M)FDA LinkGeneric 01/2017 - 12/2013
3	polyethylene glycol 2000IBA 01/2017 - 12/2014
2	MicroRNAs (MicroRNA)IBA 05/2022 - 01/2019
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2017 - 12/2014
2	Polyglactin 910IBA 01/2017 - 01/2015
2	DNA (Deoxyribonucleic Acid)IBA 07/2016 - 12/2013
2	LigandsIBA 01/2016 - 01/2015
2	Bovine Serum AlbuminIBA 05/2015 - 03/2015
2	Lipoproteins (Lipoprotein)IBA 05/2015 - 03/2015
2	LipidsIBA 05/2015 - 03/2015
2	Silicon Dioxide (Silica)FDA LinkGeneric 01/2015 - 01/2015
2	tLyP-1 peptideIBA 01/2015 - 01/2015
2	Bee Venoms (Bee Venom)IBA 08/2006 - 01/2006
1	BoratesIBA 07/2022
1	Immune Checkpoint InhibitorsIBA 07/2022
1	PlatinumIBA 07/2022
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 07/2022
1	EstersIBA 07/2022
1	B7-H1 AntigenIBA 07/2022
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2022
1	ProdrugsIBA 01/2022
1	2,3-dimethylmaleic anhydrideIBA 01/2022
1	AntigensIBA 01/2022
1	IntegrinsIBA 01/2022
1	Biological ProductsIBA 01/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	4- (2- (2- hydroxycyclohexylamino)benzothiazol- 6- yloxy)pyridine- 2- carboxylic acid methylamideIBA 01/2022
1	CamptothecinIBA 01/2022
1	Macrophage Colony-Stimulating FactorIBA 01/2022
1	Peroxynitrous Acid (Peroxynitrite)IBA 01/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2022
1	cinnamaldehyde (cinnamic aldehyde)FDA Link 01/2022
1	AmidesIBA 12/2021
1	Glutathione (Reduced Glutathione)IBA 08/2021
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 08/2021
1	phthalocyanineIBA 08/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2021
1	amsonic acid (DAS)IBA 10/2020
1	Dasatinib (BMS 354825)FDA Link 10/2020
1	Hydroxyl RadicalIBA 12/2019
1	RG7388IBA 12/2019
1	PAMAM StarburstIBA 12/2019
1	ResveratrolIBA 01/2019
1	Docetaxel (Taxotere)FDA Link 01/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	VaccinesIBA 01/2019
1	Zoledronic Acid (Zometa)FDA Link 01/2019
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 11/2018
1	Neuroprotective AgentsIBA 11/2018
1	ChloridesIBA 01/2018
1	Biotin (Vitamin H)FDA Link 01/2018
1	alpha-Tocopherol FDA Link 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Polo-Like Kinase 1IBA 01/2018
1	CholesterolIBA 01/2018
1	Dequalinium (Dequalinium Chloride)IBA 01/2018
1	poly(lactide) (polylactic acid)IBA 09/2017
1	methoxy poly(ethylene glycol)-poly(lactide)IBA 09/2017
1	NanovaccinesIBA 06/2017
1	Nanoparticle Drug Delivery SystemIBA 06/2017
1	Histidine (L-Histidine)FDA Link 01/2017
1	Dextrans (Dextran)FDA Link 01/2017
1	Dendrimers (Dendrons)IBA 01/2016
1	peptide AIBA 01/2016
1	human ERBB2 proteinIBA 01/2016
1	Poly(amidoamine)IBA 01/2016
1	CurcuminIBA 12/2015

Therapy/Procedure

14	Therapeutics 01/2022 - 01/2006
12	Immunotherapy 07/2022 - 08/2006
7	Drug Therapy (Chemotherapy) 01/2022 - 01/2015
4	Lasers (Laser) 05/2022 - 11/2014
2	Photothermal Therapy 05/2022 - 01/2015
2	Intravenous Administration 12/2019 - 06/2018